Windtree Therapeutics, Inc. (WINT)
OTCMKTS
· Delayed Price · Currency is USD
0.0750
+0.0011 (1.49%)
At close: Sep 26, 2025
Windtree Therapeutics Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
14
Market Cap
2.52M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Tian'an Technology Group | 2.12M |
| Elite Pharmaceuticals | 105.45M |
| Glass House Brands | 221.55M |
| Northwest Biotherapeutics | 1.09M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| AMJ Global Technology | 39.00 |
Windtree Therapeutics News
- 25 days ago - Windtree Therapeutics Stockholders Approve Key Proposals for Revenue and Profit Generation at ... - GuruFocus
- 5 weeks ago - BNB treasury firm plunges 77% after Nasdaq delisting notice - Cointelegraph
- 6 weeks ago - Windtree Announces Istaroxime has been Chosen for a Plenary Session Presentation at the Heart Failure Society of America 2025 - GlobeNewsWire
- 2 months ago - Windtree Therapeutics Announces Large Reduction of Preferred Series C and D Shares Outstanding by Conversion and Redemption - GlobeNewsWire
- 2 months ago - BNB Rebounds to $780 After $520M Windtree Buy Commitment, Shows Signs of Stabilizing - CoinDesk
- 2 months ago - Windtree Therapeutics announces $520M in new funding to amplify cryptocurrency treasury strategy - Seeking Alpha
- 2 months ago - Windtree Therapeutics Announces Up To $520 Million in New Funding to Amplify BNB Cryptocurrency Treasury Strategy - GlobeNewsWire
- 2 months ago - Kraken to Support Biotech Firm Windtrees $200M BNB Treasury Play - CoinDesk